Atossa Therapeutics (ATOS) Total Debt (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Total Debt of $12531.0 for Q2 2015, up 4.18% year-over-year from $12028.0 in Q2 2014, and down 50.33% quarter-over-quarter from $25230.0 in Q1 2015.
Atossa Therapeutics (ATOS) Total Debt (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Total Debt for 5 consecutive years, with $12531.0 the latest figure, recorded in Q2 2015.
- In Q2 2015, Total Debt rose 4.18% year-over-year to $12531.0; the TTM figure through Jun 2015 stood at $12531.0 (up 4.18% YoY), while the FY2014 annual figure was $49216.0, down 77.35% from the prior year.
- Total Debt retreated to $12531.0 in Q2 2015 per ATOS's latest filing, from $25230.0 in the prior quarter.
- Across five years, Total Debt topped out at $1.0 million in Q4 2011 and bottomed at $3385.0 in Q3 2014.
- Historically, Total Debt has averaged $206874.4 across 5 years, with a median of $72708.5 in 2014.
- Annual changes were most pronounced in 2013 — Total Debt soared 61.14% — and 2014, when it sank 99.16%.
- Atossa Therapeutics' Total Debt stood at $1.0 million in 2011, then slumped by 75.0% to $250000.0 in 2012, then retreated by 13.07% to $217313.0 in 2013, then slumped by 77.35% to $49216.0 in 2014, then plunged by 74.54% to $12531.0 in 2015.
- Business Quant data shows ATOS's Total Debt at $12531.0 in Q2 2015, $25230.0 in Q1 2015, and $49216.0 in Q4 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 12,531.00 |
| Mar 31, 2015 | 25,230.00 |
| Dec 31, 2014 | 49,216.00 |
| Sep 30, 2014 | 3,385.00 |
| Jun 30, 2014 | 12,028.00 |
| Mar 31, 2014 | 96,201.00 |
| Dec 31, 2013 | 217,313.00 |
| Sep 30, 2013 | 402,840.00 |
| Sep 30, 2012 | 250,000.00 |
| Dec 31, 2011 | 1.00 Mn |